Healthcare
Live Price
Offline$1.08
-1.82% today
1Y Change
-50.67%
Window
Jun 26, 2025 → Jun 16, 2026
Coverage: 244 bars · Jun 26, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Inovio Pharmaceuticals, Inc. (INO) is a Healthcare stock with a market cap of $60.00M and listed on NASDAQ. The stock last traded around $1.08 and down 50.7% across the available one-year price window (Jun 26, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of -70.0%, EPS growth of +54.2%, a dividend yield of 0.0%. What stands out right now is revenue -70.0%, EPS +54.2%, free cash flow +15.0% with operating margin -132871.3% and ROIC -259.4%. Valuation already assumes a fairly strong business story at price/sales 918.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines INO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
INO
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
INO Max Drawdown
-63.41%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for INO and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
-70.0%
EPS Growth
+54.2%
Gross Margin
-2189.0%
Net Margin
-130000.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.